In commercial broiler and layer integrations, Beiqi Wuji Granules veterinary-grade API is administered as a non-sterile oral solution at a working concentration of 0.05–0.20% w/v in clean drinking water for 3–5 consecutive days, with a maximum stock solution concentration of 5.0% w/v when prepared in 316L stainless steel mixing vessels. Compliance for this route is framed by the finished feed or veterinary medicinal product classification in the destination market; for feed-use contexts, the operation aligns with Regulation (EC) No 183/2005 Annex II hygiene provisions and ISO 22000:2018 clause 8.5.4 hazard control, while therapeutic claims require registration under the applicable veterinary medicinal product framework such as Directive 2001/82/EC or the relevant national veterinary pharmacopoeia. In production, the granule is first screened through a 100 µm in-line bag filter and then a 50 µm strainer to remove insoluble carrier fragments before the stock solution is metered into the drinking line at a dilution ratio of 1:20 to 1:100 using a diaphragm metering pump with a turndown ratio of 10:1 and an accuracy of ±2% of set point. Water pH is maintained between 6.5 and 7.5, and water temperature is held at 20±5°C because alkaline pH above 8.0 accelerates oxidative browning and reduces soluble active recovery after 4 h of standing time. Chlorinated drinking water at free chlorine levels above 2.0 mg/L should be dechlorinated by storage in an open tank with aeration for 12 h or by passage through an activated carbon column, as residual chlorine attacks the active marker fraction and produces a measurable drop in pH. Once diluted, the oral solution is consumed within 12 h to stay within the microbiological limits for non-sterile aqueous liquids described in Ph. Eur. 5.1.4; in high ambient temperature sheds above 32°C, the use window narrows to 6 h. Terminal product formats include water-soluble powder sachets of 100 g, 500 g, and 1 kg in low-density polyethylene-lined aluminium foil, and oral liquid concentrates of 5 L and 20 L in high-density polyethylene jerrycans, with shelf-life claims restricted by moisture ingress after first opening.

Swine Premix Granule Loading and Pellet Die Thermal Boundaries

Nursery and grow-out feed mills incorporate the granular API into a mineral–carrier premix at 8–12 wt% of the premix to achieve a final complete feed inclusion of 400–600 g/t, a loading deliberately set above the 0.1% threshold to compensate for post-pelleting losses of heat-labile marker compounds. Compliance under feed legislation requires that the premix plant operate under Regulation (EC) No 183/2005 Annex II and maintain prerequisite programmes audited against ISO 22000:2018 clause 8.5.2, while the product data package for the active granule must define heavy metal and aflatoxin limits in accordance with the destination market’s Feed Materials Register or AAFCO Official Publication. Bulk blending is performed in a 6 m³ horizontal ribbon mixer with a fill factor of 60–70% and a mixing speed of 12–14 rpm for 6–8 min, targeting a coefficient of variation of ≤5% for the marker compound; longer blend times above 12 min do not improve homogeneity but produce electrostatic adhesion to the mixer walls and subsequent batch-to-batch carry-over. The downstream pelleted feed line runs a conditioner at 70–80°C for 30–45 s, followed by a ring die with a compression ratio of 1:8 and a pellet diameter of 2.5–3.5 mm; die outlet temperature is held below 85°C because published forced-degradation data for this configuration is limited, and production records from commercial lines show that post-pellet active recovery is 92–95% when the outlet temperature does not exceed 78°C. Terminal products include 1 kg, 5 kg, and 25 kg printed multi-wall paper bags with an inner polyethylene liner, pelleted creep feed and complete grow-out feed for swine, and a top-dress powder variant for on-farm mixing at 250–500 g/t.

Ruminant oral bolus and tablet production relies on direct compression rather than wet granulation to avoid exposing the hygroscopic carrier to aqueous binder systems, and the granular API is blended at 10–20 wt% of the tablet mass. Compliance for this dosage form is assessed using Ph. Eur. 2.9.5 uniformity of mass, USP <701> disintegration with a limit of ≤15 min in water at 37±2°C for uncoated tablets, and USP <1216> friability with a limit of ≤1.0%; because these are oral veterinary products, the manufacturing site also maintains current good manufacturing practice appropriate to veterinary medicinal products or medicated feed additives in the target market. The tablet blend incorporates 10–20 wt% of the API granule with 35–45 wt% microcrystalline cellulose PH102, 25–35 wt% dibasic calcium phosphate dihydrate as a densifying carrier, 2–5 wt% sodium starch glycolate as disintegrant, and 0.5 wt% magnesium stearate as lubricant. Mixing is executed in a 0.5 m³ V-blender at 15 rpm for 20 min without an intensifier bar, and the granule is screened through a 1.0 mm sieve before charging to prevent agglomerates from surviving the compression stage. Compression on a 16-station rotary tablet press with 16 mm flat-face bevel-edge B tooling runs at 20–30 rpm with a compression force of 8–12 kN, producing tablets with hardness of 80–130 N and thickness of 5.0–6.5 mm; compression force above 14 kN causes capping because the granule’s particle size distribution shifts toward fines during extended press runs. Terminal products include 1 g, 2 g, and 5 g bovine and ovine oral boluses, as well as 300 mg and 500 mg tablets packed in high-density polyethylene bottles with induction-sealed closures and desiccant canisters.

Can Capsule Filling Maintain Fill Weight Uniformity Below 5% RSD for Companion Animal Dose Units?

For companion animal dose units, capsule filling of the API granule is performed on a dosator-type automatic capsule filling machine operating at 30,000–60,000 capsules per hour, with size 1 or 0 hard gelatin capsules selected to accommodate target fill weights of 350–450 mg and an active granule content of 5–15 wt%. Compliance for this product class is bifurcated: if the capsule is placed on a veterinary prescription or therapeutic claim, current good manufacturing practice follows 21 CFR 210 and 211, while feed/supplement positioning in the United States falls under 21 CFR 507 preventive controls for animal food and the AAFCO Official Publication ingredient listing requirements; in Canada, the product would be assessed under the Feeds Regulations and the relevant good manufacturing practice guidance. Prior to encapsulation, the granule is dried to moisture ≤5.0% in a fluidized-bed drier with inlet air at 55–60°C and exhaust relative humidity of 20–25%, because residual moisture above 6.0% softens the gelatin shell and causes fill weight variation above 5% RSD after 8 h of continuous encapsulation in a non-dehumidified suite. The powder blend is prepared in a 150 L bin blender at 10 rpm for 15 min, with 0.5 wt% magnesium stearate passed through a 500 µm screen and added during the final 3 min. Terminal products include 100 mg and 250 mg capsules in polyvinyl chloride/aluminium blister packs with a desiccant pouch, and 60-count high-density polyethylene bottles with a child-resistant cap and induction seal; the blister format is preferred for humid climates because the granule’s hygroscopic carrier fraction causes brittleness of the gelatin shell when stored at relative humidity below 35% and softening above 60%.

When Aseptic Filling Is Required for Parenteral Veterinary Solutions

Injectable veterinary solutions containing the granular API are manufactured only after the granule is dissolved and the resulting solution is rendered sterile, because the raw granule is not sterile and the water-soluble organic matrix supports rapid microbial proliferation if held at ambient temperature. The formulation addition ratio for parenteral products is 0.5–1.0% w/v active granule solids in Water for Injection, with 0.9% w/v sodium chloride as isotonicity adjuster and pH adjustment to 6.0–7.5 using 0.1 M hydrochloric acid or sodium hydroxide; in some registered products the granule is dissolved at 40±5°C under continuous agitation with a magnetic stirrer at 300–500 rpm for 30 min. Sterility assurance is governed by 21 CFR 210 and 211, EU GMP Annex 1 for sterile manufacture, USP <71> or Ph. Eur. 2.6.1 sterility tests, USP <85> or Ph. Eur. 2.6.14 bacterial endotoxin testing with a limit of ≤0.5 EU/mg, and USP <788> or Ph. Eur. 2.9.19 particulate matter for small-volume parenterals. The bulk solution is chilled to 20±2°C, passed through a 0.45 µm polyvinylidene fluoride membrane prefilter, then through a 0.22 µm sterilizing-grade polyethersulfone filter under a pressure of ≤1.0 bar; terminal sterilisation at 121°C for 15 min is applied only where stability data demonstrate ≤5% loss of active marker, otherwise aseptic filtration is used with a sterility assurance level of ≤10⁻⁶. Terminal products include 10 mL, 20 mL, and 50 mL Type I borosilicate glass vials sealed with bromobutyl rubber stoppers and aluminium flip-off caps, and 100 mL Type II glass bottles for large-animal parenteral use; the operational boundary of this route is the absence of terminal sterilization for heat-labile fractions, requiring an isolator or restricted access barrier system in Grade A environments.

Aquafeed Extrusion Moisture Control and Active Recovery Limits in Warmwater Fish Diets

In warmwater fish and shrimp feed lines, the API granule is added to aquaculture premixes at 2–5 wt% and then diluted into extruded complete feed to a final inclusion of 0.05–0.2%, with the lower bound reserved for long-duration grow-out feeds and the upper bound for short-term stress-recovery rations. Compliance for the feed hygiene context is based on Regulation (EC) No 183/2005 Annex II, ISO 22000:2018 hazard control plans, and the Codex Alimentarius fish and fishery products code CAC/RCP 52-2003 as applicable to the processing facility; environmental and residue requirements in export markets are verified against the destination import tolerance lists for aquaculture inputs. The premix is dispersed into the extruder feed stream through a continuous loss-in-weight feeder with an accuracy of ±1.0% of set point, and the formulation is preconditioned at 90–95°C for 60–90 s before entering a twin-screw extruder with a barrel L/D ratio of 32:1, screw speed of 350–450 rpm, and barrel temperatures of 110–125°C in the third and fourth zones. Moisture of the melt is maintained at 25–28% to limit shear degradation; the die pressure is kept between 40 and 60 bar, and die diameter is 3–5 mm for floating feeds and 1–2 mm for sinking shrimp crumbles. Post-extrusion active recovery in production samples is 85–90% when the barrel temperature does not exceed 125°C and the residence time is ≤30 s; above 130°C, recovery declines sharply to below 70%, which imposes an upper operational limit on the extrusion profile. Terminal products include 1–5 mm extruded and dried fish pellets, slow-sinking shrimp feeds, and vacuum-packed 25 kg aquaculture premix bags with desiccant-lined multi-wall construction; the final moisture after drying is 8–10% to prevent mould growth without over-drying the hygroscopic granule.